Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 5, 2011, Pages 635-640

  Ra, S W ^a   Lyu, J ^a   Choi, C M ^a   Oh, Y M ^a   Lee, S D ^a   Kim, W S ^a   Kim, D S ^a   Shim, Tae Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Interferon gamma release assay; Mycobacterium avium intracellulare infection; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 79954486066     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0485     Document Type: Article

References (30)

1. Prince D S, Peterson D D, Steiner R M, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868.
2. Koh W J, Kwon O J, Ham H S, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens. Korean J Med 2003; 65: 10-21.
3. Ostroff S, Hutwagner L, Collin S. Mycobacterial species and drug resistance patterns reported by state laboratories - 1992. 93rd American Society for Microbiology General Meeting 1993. Washington DC, USA: ASM, 170 [Abstract U-9].
4. Centers for Disease Control and Prevention. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009; 58: 7-10.
5. Lew W J, Lee E G, Bai J Y, et al. An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis 2006; 10: 1241-1247. (Pubitemid 44713478)
6. Jeon K, Koh W J, Kwon O J, et al. Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tuberc Lung Dis 2005; 9: 1046-1051. (Pubitemid 41549194)
7. Lee J, Choi H, Lee H, et al. Recovery rate and characteristics of nontuberculous mycobacterial isolates in a university hospital in Korea. Tuberc Respir Dis 2005; 58: 385-391. (Pubitemid 40943972)
8. von Reyn C F, Green P A, McCormick D, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative: an open study of patients with M. avium complex infection or tuberculosis. Clin Infect Dis 1994; 19: 15-20.
9. von Reyn C F, Williams D E, Horsburgh C R Jr, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998; 177: 730-736. (Pubitemid 28099890)
10. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 2006; 43: 1540-1546. (Pubitemid 44901894)
11. Detjen A K, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322-328. (Pubitemid 47101028)
12. Wang J Y, Chou C H, Lee L N, et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis 2007; 13: 553-558.
13. Adams L V, Waddell R D, Von Reyn C F. T-SPOT.TB Test(R) results in adults with Mycobacterium avium complex pulmonary disease. Scand J Infect Dis 2008; 40: 196-203.
14. Kobashi Y, Mouri K, Yagi S, et al. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 2009; 13: 1422-1426.
15. Latorre I, De Souza-Galvao M, Ruiz-Manzano J, et al. Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J 2010; 35: 338-342.
16. Griffith D E, Aksamit T, Brown-Elliott B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
17. Lee H, Park H J, Cho S N, Bai G H, Kim S J. Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol 2000; 38: 2966-2971. (Pubitemid 30640582)
18. Geiter L, Gordin F, Hershfield E, et al. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (Suppl): S221-247.
19. Mazurek G H, Villarino M E. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 15-18.
20. Desem N, Jones S L. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 1998; 5: 531-536. (Pubitemid 28342883)
21. Mazurek G H, LoBue P A, Daley C L, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747. (Pubitemid 33010260)
22. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64. (Pubitemid 38997752)
23. Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 44: 74-77.
24. Lange C, Pai M, Drobniewski F, Migliori G B. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 2009; 33: 1250-1253.
25. Park S Y, Jeon K, Um S W, Kwon O J, Kang E S, Koh W J. Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis 2009; 41: 818-822.
26. Centers for Disease Control and Prevention. Trends in tuberculosis - United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 281-285.
27. Yamada T, Nakajima A, Inoue E, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 2006; 65: 1661-1663. (Pubitemid 44799684)
28. Caminero J A, Cayla J A, Lara N. Evaluation of tuberculosis trends in Spain, 1991-1999. Int J Tuberc Lung Dis 2003; 7: 236-242.
29. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6: 413-422. (Pubitemid 44174345)
30. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis. Chest 2010; 137: 952-968.